Acute administration of nicotine induces transient elevation of blood pressure and increases myocardial infarct size in rats.
Authors:
Journal: Heliyon
Publication Type: Journal Article
Date: 2020
DOI: PMC7680768
ID: 33251352
Abstract
We investigated the acute effects of nicotine on myocardial infarct size, no reflow, hemodynamics and cardiac function in an acute myocardial ischemia and reperfusion infarction rat model.
Reference List
- Ding N., Sang Y., Chen J. Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases. J. Am. Coll. Cardiol. 2019;74:498–507.|||Morris P.B., Ference B.A., Jahangir E. Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the prevention of cardiovascular disease section leadership council and early career councils of the American college of Cardiology. J. Am. Coll. Cardiol. 2015;66:1378–1391.|||Campbell S.C., Moffatt R.J., Stamford B.A. Smoking and smoking cessation the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008;201:225–235.|||Andersson K., Arner P. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. Int. J. Obes. Relat. Metab. Disord. 2001;25:1225–1232.|||Benowitz N.L. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog. Cardiovasc. Dis. 2003;46:91–111.|||Czernin J., Waldherr C. Cigarette smoking and coronary blood flow. Prog. Cardiovasc. Dis. 2003;45:395–404.|||Neunteufl T., Heher S., Kostner K. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J. Am. Coll. Cardiol. 2002;39:251–256.|||Virdis A., Giannarelli C., Neves M.F., Taddei S., Ghiadoni L. Cigarette smoking and hypertension. Curr. Pharmaceut. Des. 2010;16:2518–2525.|||Ghosh S., Drummond M.B. Electronic cigarettes as smoking cessation tool: are we there? Curr. Opin. Pulm. Med. 2017;23:111–116.|||Hartmann-Boyce J., McRobbie H., Bullen C., Begh R., Stead L.F., Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst. Rev. 2016;9:CD010216.|||DeVito E.E., Krishnan-Sarin S. E-cigarettes: impact of E-liquid components and device characteristics on nicotine exposure. Curr. Neuropharmacol. 2018;16:438–459.|||Sridharan M.R., Flowers N.C., Hand R.C., Hand J.W., Horan L.G. Effect of various regimens of chronic and acute nicotine exposure on myocardial infarct size in the dog. Am. J. Cardiol. 1985;55:1407–1411.|||Zhu B.Q., Sun Y.P., Sievers R.E., Glantz S.A., Parmley W.W., Wolfe C.L. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation. 1994;89:1282–1290.|||Zhu B.Q., Sievers R.E., Browne A.E. The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke. J. Renin-Angiotensin-Aldosterone Syst. 2002;3:54–60.|||Khanna A.K., Xu J., Mehra M.R. Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model. Lab. Invest. 2012 Feb;92(2):224–235.|||Bibli S.I., Andreadou I., Glynos C. Exposure to cigarette smoke abrogates the beneficial effect of ischemic postconditioning. Am. J. Physiol. Heart Circ. Physiol. 2016 Nov 1;311(5)|||Birnbaum Y., Hale S.L., Kloner R.A. Is preconditioning by nicotine responsible for the better prognosis in smokers with acute myocardial infarction? Basic Res. Cardiol. 1996;91:240–247.|||Li Y., Kloner R.A. Is there a gender difference in infarct size and arrhythmias following experimental coronary occlusion and reperfusion? J. Thromb. Thrombolysis. 1995;2(3):221–225.|||Dow J.S., Bhandari A., Hale S.L., Kloner R.A. Does sex influence the incidence or severity of reperfusion-induced cardiac arrhythmias? SpringerPlus. 2015 Feb 26;4:96.|||Mayhan W.G., Patel K.P. Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo. Am. J. Physiol. 1997;272:H2337–2342.|||Dai W., Herring M.J., Hale S.L., Kloner R.A. Rapid surface cooling by ThermoSuit system dramatically reduces scar size, prevents post-infarction adverse left ventricular remodeling, and improves cardiac function in rats. J. Am. Heart Assoc. 2015 Jun 26;4(7)|||Yan X.S., D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul. Toxicol. Pharmacol. 2015;71:24–34.|||Vansickel A.R., Weaver M.F., Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction. 2012;107:1493–1500.|||Benowitz N.L., Burbank A.D. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc. Med. 2016;26:515–523.|||Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tobac. Contr. 2010;19:87–88. American Journal of Cardiology. 2019;124(5):666-670.|||Benowitz N.L., Fraiman J.B. Cardiovascular effects of electronic cigarettes. Nat. Rev. Cardiol. 2017;14:447–456.|||Pedrinelli R., Ballo P., Fiorentini C. Hypertension and acute myocardial infarction: an overview. J. Cardiovasc. Med. (Hagerstown) 2012;13:194–202.|||Middlekauff H.R., Park J., Moheimani R.S. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J. Am. Coll. Cardiol. 2014;64:1740–1750.|||Shinozaki N., Yuasa T., Takata S. Cigarette smoking augments sympathetic nerve activity in patients with coronary heart disease. Int. Heart J. 2008;49:261–272.|||Cruz S.L., Vidrio H. Tachyphylaxis and sensitization to nicotine-induced Tachycardiac and pressor effects after nicotine infusions. Arch. Med. Res. 1997;28:189–194.|||Marano G., Ramirez A., Mori I., Ferrari A.U. Sympathectomy inhibits the vasoactive effects of nicotine in conscious rats. Cardiovasc. Res. 1999;42:201–205.|||Aceto M.D., Tucker S.M., Ferguson S., Hinson J.R. Rapid and brief tolerance to (+)- and (−)-nicotine in unanesthetized rats. Eur. J. Pharmacol. 1986;132:213–218.|||Kiritsy-Roy J.A., Mousa S.A., Appel N.M., Van Loon G.R. Tolerance to nicotine-induced sympathoadrenal stimulation and cross- tolerance to stress: differential central and peripheral mechanisms in rats. Neuropharmacology. 1990;29:579–589.|||Donny E.C., Caggiula A.R., Sweitzer M. Self-administered and yoked nicotine produce robust increases. Pharmacol. Biochem. Behav. 2011 September;99(3):459–467.|||Hausenloy D.J., Yellon D.M. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 2013;123:92–100.|||Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N. Engl. J. Med. 2007;357:1121–1135.|||Intachai K., S CC, Chattipakorn N., Shinlapawittayatorn K. Revisiting the cardioprotective effects of acetylcholine receptor activation against myocardial ischemia/reperfusion injury. Int. J. Mol. Sci. 2018;19|||Filippini P., Cesario A., Fini M., Locatelli F., Rutella S. The Yin and Yang of non-neuronal alpha7-nicotinic receptors in inflammation and autoimmunity. Curr. Drug Targets. 2012;13:644–655.|||Chalon S., Moreno H., Benowitz N.L., Hoffman B.B., Blaschke T.F. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin. Pharmacol. Ther. 2000;67:391–397.|||Neunteufl T., Heher S., Kostner K. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J. Am. Coll. Cardiol. 2002;39:251–256.|||Arefalk G., Hergens M.-P., Ingelsson E. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. Eur. J .Prev. Cardiol. 2012;19:1120–1127.|||Joukar S., Bashiri H., Dabiri S. Cardiovascular effects of black tea and nicotine alone or in combination against experimental induced heart injury. J. Physiol. Biochem. 2012;68:271–279.|||Zainalabidin S., Budin S.B., Ramalingam A., Lim Y.C. Aortic remodelling in chronic nicotine-administered rat. Korean J. Physiol. Pharmacol. 2014;18:411–418.|||Si L.Y., Kamisah Y., Ramalingam A., Lim Y.C., Budin S.B., Zainalabidin S. Roselle supplementation prevents nicotine-induced vascular endothelial dysfunction and remodelling in rats. Appl. Physiol. Nutr. Metabol. 2017;42:765–772.|||Li J., Liu S., Cao G. Nicotine induces endothelial dysfunction and promotes atherosclerosis via GTPCH1. J. Cell Mol. Med. 2018;22:5406–5417.|||Przyklenk K. Nicotine exacerbates postischemic contractile dysfunction of 'stunned' myocardium in the canine model. Possible role of free radicals. Circulation. 1994;89:1272–1281.|||Schror K., Zimmermann K.C., Tannhauser R. Augmented myocardial ischaemia by nicotine--mechanisms and their possible significance. Br. J. Pharmacol. 1998;125:79–86.|||Hu N., Guo R., Han X., Zhu B., Ren J. Cardiac-specific overexpression of metallothionein rescues nicotine-induced cardiac contractile dysfunction and interstitial fibrosis. Toxicol. Lett. 2011;202:8–14.|||Huang C., Guo X., Zhao H. Nicotine induces H9C2 cell apoptosis via Akt protein degradation. Mol. Med. Rep. 2017;16:6269–6275.|||Zhou X., Sheng Y., Yang R., Kong X. Nicotine promotes cardiomyocyte apoptosis via oxidative stress and altered apoptosis-related gene expression. Cardiology. 2010;115:243–250.|||Carnevale R., Sciarretta S., Violi F. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016;150:606–612.|||Ramalingam A., Budin S.B., Mohd Fauzi N., Ritchie R.H., Zainalabidin S. Angiotensin II type I receptor antagonism attenuates nicotine-induced cardiac remodeling, dysfunction, and aggravation of myocardial ischemia-reperfusion injury in rats. Front. Pharmacol. 2019;10:1493.|||Kloner R.A. Stunned and hibernating myocardium: where are we nearly 4 decades later? J. Am. Heart Assoc. 2020;9(3)|||U.S. Department of Health and Human Services . NCBI; 2010. How Tobacco Smoke Causes Disease: the Biology and Behavioral Basis for Smoking-Attributable Disease: Report of the Surgeon General; p. 60.http://www.ncbi.nlm.nih.gov/books/NBK53017/pdf/BookshelfNBK53017.pdf|||Carter B.D., Freedman N.D., Jacobs E.J. Smoking and mortality — beyond established causes. N. Engl. J. Med. 2015;372:631–640.|||Franzen K.F., Willig J., Cayo Talavera S. E-cigarettes and cigarettes worsen peripheral and central hemodynamics as well as arterial stiffness: a randomized, double-blinded pilot study. Vasc. Med. 2018;23:419–425.|||Vlachopoulos C., Ioakeimidis N., Abdelrasoul M. Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers. J. Am. Coll. Cardiol. 2016;67:2802–2803.|||Chaumont M., de Becker B., Zaher W. Differential effects of E-cigarette on microvascular endothelial function, arterial stiffness and oxidative stress: a randomized crossover trial. Sci. Rep. 2018;8:10378.|||Loffredo L., Carnevale R., Perri L. NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate. Heart. 2011;97:1776–1781.|||Wong N.D., Gransar H., Narula J. Myeloperoxidase, subclinical atherosclerosis,and cardiovascular disease events. JACC Cardiovasc. Imaging. 2009;2:1093–1099.|||Alzahrani T., Pena I., Temesgen N., Glantz S.A. Association between electronic cigarette use and myocardial infarction. Am. J. Prev. Med. 2018;55(4):455–461.|||Skotsimara G., Antonopoulos A.S., Oikonomou E. Cardiovascular effects of electronic cigarettes: a systematic review and meta-analysis. Eur. J .Prev. Cardiol. 2019;26:1219–1228.|||Brunetti R., Hicklin H., Rackley J., Ahmad M.I., Li Y.B., Soliman E.Z. Serum cotinine and silent myocardial infarction in individuals free from cardiovascular disease. Am. J. Cardiol. 2019;124(5):666–670.